Jane Street
EGRX

Jane Street’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Jane Street’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,837
Closed -$96.4K – 10978
2024
Q3 		$96.4K Buy
+25,837
New +$123K ﹤0.01% 9003
2024
Q1 		– Sell
-23,626
Closed -$124K – 10294
2023
Q4 		$124K Buy
+23,626
New +$233K ﹤0.01% 8489
2023
Q3 		– Sell
-47,693
Closed -$927K – 9574
2023
Q2 		$927K Sell
47,693
-17,184
-26% -$408K ﹤0.01% 5314
2023
Q1 		$1.84M Buy
64,877
+43,430
+202% +$1.29M ﹤0.01% 3969
2022
Q4 		$627K Buy
+21,447
New +$682K ﹤0.01% 5745
2022
Q3 		– Sell
-12,620
Closed -$561K – 10677
2022
Q2 		$561K Buy
12,620
+3,278
+35% +$151K ﹤0.01% 6514
2022
Q1 		$462K Buy
9,342
+1,655
+22% +$79.4K ﹤0.01% 7637
2021
Q4 		$391K Buy
7,687
+2,399
+45% +$124K ﹤0.01% 7697
2021
Q3 		$295K Buy
+5,288
New +$260K ﹤0.01% 8229
2021
Q1 		– Sell
-7,900
Closed -$368K – 9695
2020
Q4 		$368K Sell
7,900
-1,214
-13% -$56.8K ﹤0.01% 6135
2020
Q3 		$387K Buy
+9,114
New +$399K ﹤0.01% 5538
2018
Q2 		– Sell
-4,021
Closed -$212K – 5758
2018
Q1 		$212K Buy
+4,021
New +$234K ﹤0.01% 4402
2017
Q3 		– Sell
-3,073
Closed -$242K – 5205
2017
Q2 		$242K Buy
3,073
+420
+16% +$34.3K ﹤0.01% 3836
2017
Q1 		$220K Buy
+2,653
New +$197K ﹤0.01% 3770
2016
Q2 		– Sell
-5,112
Closed -$213K – 4710
2016
Q1 		$207K Buy
+5,112
New +$324K ﹤0.01% 3669
2015
Q4 		– Sell
-6,699
Closed -$496K – 4569
2015
Q3 		$496K Buy
6,699
+1,372
+26% +$114K ﹤0.01% 2315
2015
Q2 		$431K Sell
5,327
-2,798
-34% -$182K ﹤0.01% 2447
2015
Q1 		$340K Buy
+8,125
New +$231K ﹤0.01% 2413

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Jane Street's EGRX Position: Q4 2024 in Review

Jane Street sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 25,837 shares — an estimated $96.4K sold.

Jane Street first reported a position in EGRX in Q1 2015 and held it in 18 quarters. The position peaked at $1.84M in Q1 2023. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Jane Street reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 25,837 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $96.4K.
  • Jane Street first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and held it in 18 quarters.
  • Jane Street's Eagle Pharmaceuticals, Inc. position peaked at $1.84M in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.